382 related articles for article (PubMed ID: 25916569)
21. Laser lead extraction allows for safe and effective removal of single- and dual-coil implantable cardioverter defibrillator leads: A single-centre experience over 12 years.
Pecha S; Yildirim Y; Gosau N; Aydin MA; Willems S; Treede H; Reichenspurner H; Hakmi S
Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):77-81. PubMed ID: 27624353
[TBL] [Abstract][Full Text] [Related]
22. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study.
Cantillon DJ; Ha K; Styperek R; Jumrussirikul P; Mirro M; Wong W; Wilkoff BL
Pacing Clin Electrophysiol; 2013 Jul; 36(7):855-62. PubMed ID: 23617316
[TBL] [Abstract][Full Text] [Related]
24. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
Healey JS; Hohnloser SH; Glikson M; Neuzner J; Mabo P; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Pogue J; Appl U; Gilkerson J; Pochet T; Stein KM; Merkely B; Chrolavicius S; Meeks B; Foldesi C; Thibault B; Connolly SJ;
Lancet; 2015 Feb; 385(9970):785-91. PubMed ID: 25715991
[TBL] [Abstract][Full Text] [Related]
25. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators.
Bhavnani SP; Kluger J; Coleman CI; White CM; Guertin D; Shafi NA; Yarlagadda RK; Clyne CA
Heart Rhythm; 2010 Jun; 7(6):755-60. PubMed ID: 20211275
[TBL] [Abstract][Full Text] [Related]
26. Gender-Related and Age-Related Differences in Implantable Defibrillator Recipients: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
Feldman AM; Kersten DJ; Chung JA; Asheld WJ; Germano J; Islam S; Cohen TJ
J Invasive Cardiol; 2015 Dec; 27(12):530-4. PubMed ID: 26630641
[TBL] [Abstract][Full Text] [Related]
27. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.
MacFadden DR; Crystal E; Krahn AD; Mangat I; Healey JS; Dorian P; Birnie D; Simpson CS; Khaykin Y; Pinter A; Nanthakumar K; Calzavara AJ; Austin PC; Tu JV; Lee DS
Ann Intern Med; 2012 Feb; 156(3):195-203. PubMed ID: 22312139
[TBL] [Abstract][Full Text] [Related]
28. Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study.
Stockburger M; Moss AJ; Olshansky B; Klein H; McNitt S; Schuger C; Daubert JP; Goldenberg I; Ruwald AC; Merkely B; Zareba W; Kutyifa V
Europace; 2015 Jul; 17(7):1085-91. PubMed ID: 25745075
[TBL] [Abstract][Full Text] [Related]
29. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
[TBL] [Abstract][Full Text] [Related]
30. Predictors of pacemaker dependence and pacemaker dependence as a predictor of mortality in patients with implantable cardioverter defibrillator.
Sood N; Crespo E; Friedman M; Guertin D; Zweibel S; Kluger J; Clyne CA
Pacing Clin Electrophysiol; 2013 Aug; 36(8):945-51. PubMed ID: 23668483
[TBL] [Abstract][Full Text] [Related]
31. Reasons for and predictors of acute hospitalization versus elective outpatient implantable cardioverter-defibrillator implantation and subsequent differential clinical outcomes.
Nishimura M; Sab S; Birgersdotter-Green U; Krummen D; Schricker A; Raissi F; Hoffmayer KS; Feld GK; Hsu JC
J Interv Card Electrophysiol; 2017 Oct; 50(1):85-93. PubMed ID: 28844089
[TBL] [Abstract][Full Text] [Related]
32. Failure rates of single- versus dual-coil nonrecalled sprint quattro defibrillator leads.
Shariff N; Alluri K; Saba S
Am J Cardiol; 2015 Jan; 115(2):202-5. PubMed ID: 25465935
[TBL] [Abstract][Full Text] [Related]
33. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
[TBL] [Abstract][Full Text] [Related]
34. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.
Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P
Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471
[TBL] [Abstract][Full Text] [Related]
35. Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications.
Jones SO; Eckart RE; Albert CM; Epstein LM
Heart Rhythm; 2008 Apr; 5(4):520-5. PubMed ID: 18325849
[TBL] [Abstract][Full Text] [Related]
36. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
[TBL] [Abstract][Full Text] [Related]
37. Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer.
Thijssen J; Borleffs CJ; van Rees JB; Man S; de Bie MK; Venlet J; van der Velde ET; van Erven L; Schalij MJ
Heart Rhythm; 2012 Apr; 9(4):513-9. PubMed ID: 22094073
[TBL] [Abstract][Full Text] [Related]
38. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
[TBL] [Abstract][Full Text] [Related]
39. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.
Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH
J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337
[TBL] [Abstract][Full Text] [Related]
40. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
